A 47-year-old womanwas referred to our hospital because of severe anemia and polyclonal gammopathy. She developed sicca syndrome after admission. Laboratory data revealed pancytopenia (white blood cells, 2,800/| ul; hemoglobin, 6.4 g/dl ; platelets, 6.1xlO4/jil) and hyper yglobulinemia (5.2 g/dl), and bone marrow was hypoplastic. Histology of the salivary gland showed infiltration of lymphocytes. Wereport a good response to immunosuppressive therapy in a rare case of aplastic anemia complicating Sjogren's syndrome.
Introduction
Sjogren's syndrome (SjS) is an autoimmune disorder characterized by lymphocytic infiltration of the salivary and lacrimal glands (1) . It has been suggested that immunological abnormalities in this syndrome may cause various hematological disorders. However,the association ofaplastic anemia with SjS has only rarely been reported (2) (3) (4) , and the pathogenesis of such anemia is obscure. This report describes a patient with aplastic anemia complicating SjS.
Case Report
A 47-year-old woman developed gingival bleeding in January 1995. After 4 months, she consulted her local doctor because of fatigue and exertional dyspnea. In June 1995, she was referred to our hospital because of severe anemia and polyclonal gammopathy. On admission, she was pale and had gingival bleeding, purpura in both legs, and erosions and vesicles in the mouth. However, there was no organomegaly, lymphadenopathy, or joint deformity. She developed sicca symptoms after admission. The initial laboratory findings are shown in Table 1 . Pancytopenia, polyclonal gammopathy with elevated serum levels of IgG, IgA and IgM were found. Antibodies to nuclear antigen and SS-A were positive and rheumatoid factor was positive with a high titer, but other antibodies were negative. Bone marrow aspiration and biopsy showed a hypoplastic marrowwith a nucleated cell count of 15,000/|il and no proliferation of blasts or plasma cells. There were no dysplastic changes in myeloid, erythroid, or megakaryocytic lineages ( Fig. 1) .
A diagnosis of aplastic anemiawas madeon the basis of pancytopenia with hypoplastic marrow. Opthalmological examination revealed diminished tear secretion by Schirmer's test (right, 4 mm; left, 4 mm). Salivary gland histology revealed interlobular and intralobular infiltration of mononuclearcells (Fig. 2) . Adiagnosis ofSjS was madedue to the absence of other collagen diseases. After admission, the platelet and neutrophil counts decreased gradually. On the 24th hospital day, prednisolone therapy (30 mg/day) was started. Her hematological status then improved gradually and her sicca symptomsalso improved. On the 56th hospital day, she was given high dose methylprednisolone (1,000 mg/day x 3 days) because of the response to prednisolone. After this therapy, her hematological status further improved with a white blood cell count of 3,000/ jil (49.0% neutrophils), a hemoglobin of 8.8 g/dl, and a platelet count of l l.lxlO4/jil. The dose of prednisolone was subsequently decreased with continued good hematological control and hyper y globulinemia was improved (Fig. 3 ).
Discussion
The association of aplastic anemia with autoimmunediseases such as systemic lupus erythematosus (SLE) has been reported (5-7), but SjS is rarely associated with aplastic anemia (2-4). SjS is characterized by an increased risk of non-Hodgkin's lymphoma. The cause is unknown, but it is speculated that the chronic immunologic hyperactivity leads to proliferation of abnormal lymphocytes (8, 9). The hypothesis that aplastic anemia might be caused by autoimmune mechanisms is based on a numerous observations, including the response to immunosuppressive therapy (10-13). A patient who had aplastic anemia complicating SLEwas reported to recover following treatment with steroids and plasmapheresis (6), while immunoglobulin obtained from the patient's serum suppressed the in vitro growth ofgranulocyte-macrophage progenitor cells (CFU-GM). Therefore, aplastic anemia associated with SLE is considered to develop because of circulating auto-antibodies (5, 7). In the case of aplastic anemia complicating SjS, Satoh et al reported that colony formation by mononuclear cells from the patient's bone marrow was decreased, but improved significantly when T cells were depleted from the culture system (3). These findings suggest that one cause ofpancytopenia in SjS is immunemechanisms, especially bone marrow-suppressive T cells. Among the four patients we were able to find with concurrent SjS and aplastic anemia, both conditions were diagnosed simultaneously in one patient (4). In the remaining three patients, SjS occurred first, with sicca symptoms being observed from two to nine years before the onset of aplastic anemia (2, 3, 14) . In the present patient, sicca symptoms appeared after hyper y globulinemia and pancytopenia. There is no doubt that the autoimmunedisorder causing SjS was related to the onset of aplastic anemia. The seriousness of aplastic anemia in the four patients ranged from severe to mild and it was categorized as mild in the present case. Thus, these does not seem to be a consistent trend with regard to the severity of aplastic anemia complicating SjS. With regard to the prognosis of concurrent SjS and aplastic anemia, a good hematological recovery was observed in the three patients with severe anemiawhenthey received immunosuppressivetherapy Aplastic Anemia and Sjogren's Syndrome using prednisolone. In the present patient, prednisolone and high-dose methylprednisolone improved both her sicca symptoms and her hematological status. Since the etiology ofaplastic anemia is still unclear, further studies are needed to clarify the true incidence and its association with autoimmune disease. 
